Have done some research and find the case for TOX compelling.The...

Have done some research and find the case for TOX compelling.

The forecast is for half year earnings of $1m net, which would translate to half a cent on an annualised basis. A very modest p/e of 10 gives an sp of 5c. Factor in upside such as the expected capacity upgrade and an sp of 10c over the next few months is not out of the question.

Cash position appears good and getting stronger with several consecutive cash positive months behind them.

As you point out T4P, the underwriter seems to be either light of shares or revising their expectations upwards. For instance, they don't appear interested in selling at 2.5c. There has been plenty of opportunity to sell at this price as the few offered have been snapped up pretty quick.

This could easily be another JUM. I hope so as I bought some TOXO today. High risk, but as I said the case appears compelling.

cosmos